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1. Introduction
With the re-emergence of tuberculosis
providing the impetus, research on Myco-
bacterium tuberculosis at the molecular level
has registered considerable progress in recent
years (Ratledge & Dale, 1999). In particular,
the availability of the complete genome
sequence of the pathogen has facilitated such
research (Cole et al., 1998). The sequence
indicates the presence of about 4000 tuber-
culosis proteins, but the three-dimensional
structures of only a few dozen of them are
currently known. As part of a continuing effort
in this laboratory to characterize the structures
of these proteins (Datta et al., 2000, 2003;
Saikrishnan et al., 2003), the crystallization and
preliminary studies of the ribosome recycling
factor (RRF) from this organism have been
carried out.
RRF is an essential factor which in concert
with elongation factor G (EFG) and in the
presence of GTP disassembles the post-termi-
nation complex consisting of 70S ribosome
bound to deacylated tRNA and mRNA (Janosi
et al., 1996). This factor is essential for eubac-
terial growth (Janosi et al., 1996). RRF is also
present in the organelles of eukaryotic cells.
However, it has been shown to be nonessential,
at least for the survival of yeast (Kaji et al.,
1998). Therefore, this makes RRF a promising
target for antibacterial drugs (Kaji et al., 1998).
The three-dimensional structure of RRF
determined from a number of Gram-negative
bacteria (Selmer et al., 1999; Kim et al., 2000;
Toyoda et al., 2000; Yoshida et al., 2001;
Nakano et al., 2002, 2003) indicates strong
conservation of its structure. The protein has a
tRNA-like `L'-shaped structure. The arms of
the `L' are formed by two domains: domain I is
a triple-helix bundle and domain II is a three-
layer ±± sandwich structure. However, the
structure of RRF from either Gram-positive
bacteria or eukaryotes has yet to be deduced.
Of the Gram-positive bacteria, RRF from
M. tuberculosis (MtRRF) has been biochemi-
cally studied (Rao & Varshney, 2001, 2002).
This protein, which is 184 residues long, shares
a sequence identity of 40% with its homologue
in Escherichia coli (EcRRF). Despite the
strong sequence similarity and overlap of many
biochemical properties, cross-species comple-
mentation experiments have demonstrated
the failure of MtRRF to function in E. coli
(Rao & Varshney, 2001). Instead, simultaneous
expression of MtEFG and MtRRF comple-
ments a temperature-sensitive RRF strain of
E. coli (Rao & Varshney, 2001). These results
not only indicate the necessity of a `cross-talk'
between RRF and EFG for the disassembly of
the post-termination complex, but also that
this interaction in M. tuberculosis is species-
speci®c. Structural information on this protein
is a necessary platform to gain further insights
into the origin of this speci®city.
2. Materials and methods
2.1. Overexpression and purification of
MtRRF
MtRRF was overexpressed and puri®ed to
apparent homogeneity using a protocol
described by Rao & Varshney (2002) with
modi®cations. E. coli BL21 (DE3) harbouring
pET11dMtRRF was used for overexpression
of the protein. The transformants were inocu-
lated into Luria±Bertani medium (Sambrook et
al., 1989) and induced with 0.5 mM IPTG at
the mid-exponential phase of growth (OD600
value between 0.3 and 0.4). The culture was
induced at 310 K. The harvested cells were
sonicated in a buffer consisting of 20 mM
phosphate pH 7.6, 10% glycerol, 2 mM
-mercaptoethanol and 1 mM EDTA and
centrifuged at 100 000g to prepare the S100
extract. The S100 extract was subjected to
streptomycin sulfate (0.9%) precipitation and
the supernatant was loaded onto a hydroxy-
apatite column (Bio-Rad). The proteins were
eluted with a linear gradient of 20 mM±1 M
phosphate pH 7.6 and 10% glycerol. The
fractions enriched in RRF were pooled and
subjected to ammonium sulfate precipitation
(70% saturation). The precipitate was recov-
ered by centrifugation, dissolved in 1 ml of
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20 mM Tris±HCl pH 7.5 and 10% glycerol
buffer and loaded onto a Superdex 75
column (Amersham Pharamacia Biotech).
The protein was eluted with a buffer
containing 20 mM Tris±HCl pH 7.5, 150 mM
NaCl and 10% glycerol buffer. The fractions
enriched in RRF were pooled and diluted
with 20 mM Tris±HCl pH 7.5 and 10%
glycerol and loaded onto a Mono Q column
(Amersham Pharmacia Biotech). The
proteins were eluted with a linear gradient
of 250±750 mM NaCl in 20 mM Tris±HCl pH
7.5 and 10% glycerol buffer. The fractions
enriched in RRF were pooled and diluted
with 20 mM phosphate pH 7.6 and 10%
glycerol and loaded onto a hydroxyapatite
column. The proteins were eluted with a
linear gradient of 100±300 mM phosphate
pH 7.6 and 10% glycerol. A ®nal prepara-
tion containing 10±15 mg mlÿ1 of this
homogeneous protein in 20 mM Tris±HCl
buffer pH 7.5 was used for crystallization
(Fig. 1a).
2.2. Crystallization and data collection
Crystals were grown using the hanging-
drop vapour-diffusion method. The drop
size varied from 5±9 ml, with a well volume
of 500 ml. The drops consisted of 4±8 ml of
protein solution and 1 ml of well solution.
The crystallization trays were stored at
298 K. The crystal from which the working
data set was collected was grown in 20 mM
Tris±HCl buffer pH 7.5 containing 6% PEG
8000 and 0.6 mM cadmium acetate (Fig. 1b).
The diffraction data were collected at room
temperature (298 K) with a MAR Research
imaging plate mounted on a Rigaku RU-200
X-ray generator. The crystal-to-image plate
distance was 100 mm. The data were
processed and scaled using the HKL
package (Otwinowski & Minor, 1997).
Intensities were converted to structure
factors using TRUNCATE (Collaborative
Computational Project, Number 4, 1994).
Structure solution was obtained by the
molecular-replacement method using
AMoRe (Navaza, 1994). The structure was
re®ned using CNS1.1 (BruÈ nger et al., 1998)
involving iterations of rigid-body and posi-
tional re®nement and simulated annealing.
3. Results and discussion
3.1. Crystallization
Initial attempts at crystallizing the protein
using commercially available screening kits
failed to produce any positive results. Efforts
were then directed towards screening
strategies involving commonly used preci-
pitating agents (McPherson, 1990). In
particular, divalent cations such as zinc,
calcium, magnesium, manganese and
cadmium that have been known to be
effective precipitating agents (McPherson,
1982, 1990; Trakhanov & Quiocho, 1995)
were tested for their ability to induce crys-
tallization of the protein. Eventually, crystals
of MtRRF were obtained from 20 mM
Tris±HCl pH 7.5 with 6% PEG 8000 and
cadmium acetate as the precipitating agents.
The other divalent cations did not yield any
crystals. Although chloride and sulfate salts
of cadmium were also tried, crystallization
occurred only with the acetate salt. The
quality of the crystals depended signi®cantly
on the concentration of cadmium acetate.
The best quality crystals grew when the
concentration of cadmium acetate was
0.6 mM. Showers of tiny crystals appeared
with increasing concentrations of the salt.
The size and quality of the crystal improved
further with the addition of 10% glycerol to
the crystallization condition. The crystals
grew to approximate dimensions of 0.6 
0.08  0.08 mm.
The role of cadmium ion in in¯uencing
crystallization has been systematically
investigated by Trakhanov and coworkers
(Trakhanov & Quiocho, 1995; Trakhanov et
al., 1998). We also have had considerable
success with cadmium salts as the precipi-
tating agent, as in the crystallization of
single-stranded DNA-binding protein from
Mycobacterium tuberculosis (Saikrishnan et
al., 2002) and DPS from M. smegmatis (Roy
et al., 2003). Cadmium ions appear to facil-
itate crystallization by cross-linking neigh-
bouring molecules through coordination
with side chains of various residues, water
and main-chain carbonyl groups (Trakhanov
et al., 1998).
3.2. Structure solution and refinement
The crystals of MtRRF belong to space
group P21, with unit-cell parameters a = 56.3,
b = 33.8, c = 62.4 AÊ , = 112.5 (Table 1). The
crystals diffracted to better than 3 AÊ reso-
lution. The Matthews coef®cient for this
crystal corresponds to a solvent content of
52.5%. A partial structure solution was
obtained by molecular replacement using
AMoRe (Navaza, 1994). Molecular replace-
ment was tried separately with all the
structures of RRF available in the Protein
Data Bank as search models. The models
were divided into three different sets: (i) full
molecules, (ii) domain I and (ii) domain II.
A single solution with a correlation coef®-
cient of 43.6% and an R factor of 44.0% was
obtained by using domain I (residues 1±35
and 105±184) of Vibrio parahaemoliticus
RRF (PDB code 1is1; Nakano et al., 2003;
non-identical residues converted to alanine)
as the search model in the resolution range
8.0±4.0 AÊ . The other search models failed to
provide a solution. The structure thus
obtained was then subjected to alternate
cycles of re®nement and model building
using the programs CNS1.1 (BruÈ nger et al.,
1998) and FRODO (Jones, 1978).
With the progress in re®nement, clear
electron densities for the linker chains that
connect the two domains and the terminal
residues of domain II (residues 36±40 and
98±104) were obtained. However, the elec-
tron densities for domain II remained
extremely poor, hindering the modelling of
this region. Earlier structural studies of RRF
had shown that the two domains move with
respect to each other with the linker region
acting as a hinge (Nakano et al., 2003). This
Figure 1
(a) 15% SDS±PAGE of puri®ed MtRRF stained with
Coomassie brilliant blue. Lane 1, marker; lane 2,
protein sample used for crystallization; lane 3,
protein recovered from the MtRRF crystals. (b)
Crystals of MtRRF.
Table 1
Crystal data and data-collection statistics.
Values in parentheses are for the highest resolution shell.
Space group P21
Unit-cell parameters
a (AÊ ) 56.3
b (AÊ ) 33.8
c (AÊ ) 62.4
 () 112.5
Packing density VM (AÊ
3 Daÿ1) 2.6
Solvent content (%) 52.5
No. molecules in the AU 1
Resolution range (AÊ ) 20.00±2.80 (2.90±2.80)
Observed re¯ections 15988
Unique re¯ections 5273 (505)
Completeness (%) 94.2 (94.9)
Rmerge (%) 11.3 (58.4)
370 Saikrishnan et al.  Ribosome recycling factor Acta Cryst. (2004). D60, 368±370
crystallization papers
motion is approximately a rotation of
domain II about the axis of the helical
bundle constituting domain I. Based on this
information and using the position of the
terminal residues of domain II, this domain
from V. parahaemoliticus (non-identical
residues converted to alanine) was placed in
the unit cell. Subsequent re®nement resulted
in a considerable decrease in R and Rfree and
in a clear electron density for the newly
added region, giving enough con®dence to
pursue this composite model. The re®ne-
ment is in progress, the current R and Rfree
values being 27.4 and 36.9%, respectively, in
the resolution range 20±2.90 AÊ .
X-ray intensity data were collected at the
X-ray Facility for Structural Biology,
supported by the Department of Science and
Technology (DST) and Biotechnology
(DBT), Government of India. Computations
were performed at the Supercomputer
Education and Research Centre at the
Institute and the Bioinformatics Centre and
the Interactive Graphics Facility, both
funded by the DBT. The work forms part of
a programme on Structural Genomics of
Microbial Pathogens supported by the DBT.
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